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I. Introduction

Molly Rose Nash was born in Colorado, on July 4, 1994.1 While
the birth of a child is usually remembered joyously, it was
immediately obvious that something was wrong with Molly, as she
was only able to emit a “sickly whimper.”2 Doctors soon realized
that Molly had been born with a genetic condition known as
Fanconi Anemia.3 Fanconi Anemia is an extremely rare genetic
condition, resulting from a genetic defect in the proteins
responsible for DNA repair.4 The condition meant that Molly’s
body was unable to produce sufficient blood cells.5 Fanconi Anemia
results in a myriad of problems, ranging from an extremely high
likelihood of developing acute myelogenous leukemia, to an over
90% chance of developing bone marrow failure.6 People with
Fanconi Anemia who manage to survive early childhood have a
high incidence of esophageal, head and neck, gastrointestinal, and
anal cancers.7 While there are treatments that can help delay bone
marrow failure, the only cure is a bone marrow transplant,8 which
is best provided by a sibling who is a match.9 Unfortunately, Molly
was an only child.10 While the Nash family originally wanted to
1. Amanda M. Faison, The Miracle of Molly, 5280 (Aug. 2005), http://www.
5280.com/2005/08/the-miracle-of-molly/ (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
2. Id.
3. Id.
4. See Alan D. D‘Andrea, Susceptibility Pathways in Fanconi‘s Anemia and
Breast Cancer, 362 NEW ENG. J. MEDICINE 1909, 1909–11 (2010) (explaining the
cause of Fanconi’s Anemia and its rarity).
5. See Faison, supra note 1 (stating that Fanconi Anemia caused Molly to
have an insufficient number of blood cells).
6. See D’Andrea, supra note 4, at 1910 (listing the symptoms and
complications that come with Fanconi’s Anemia).
7. See id. (specifying the other types of cancer that can result from
Fanconi’s Anemia).
8. See Faison, supra note 1 (“A bone marrow transplant . . . is the only cure
for progressive bone marrow failure.”); see also D’Andrea, supra note 4 (stating
that a bone marrow transplant is a viable treatment for Fanconi’s Anemia).
9. See HLA Matching, NAT’L MARROW DONOR PROGRAM, https://bethe
match.org/patients-and-families/before-transplant/find-a-donor/hla-matching/
(last visited Apr. 17, 2018) (noting that the best bone marrow donations are from
siblings) (on file with the Washington & Lee Journal of Civil Rights & Social
Justice).
10. Faison, supra note 1.
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have more children, Fanconi Anemia is an inherited condition,11
and once Molly was diagnosed, they knew they were both healthy
carriers of the genes for the disease.12 This meant that any
additional children they had could suffer the same disease as
Molly.13
There seemed to be no hope for the family, until doctors
proposed a combination of pre-implantation genetic diagnosis
(PGD) and in vitro-fertilization (IVF) that would lead to a novel
concept in the field of biomedicine: that of the savior sibling.14
Using these techniques, the physicians were able to harvest ova
and collect sperm from the Nashes, combine them in the
laboratory, and then use PGD to screen the embryo, to ensure that
it did not carry the Fanconi Anemia gene.15 After four in vitro
fertilization attempts, Lisa Nash gave birth to a baby boy, named
Adam.16 Adam’s placenta was gathered immediately and the
umbilical cord blood was saved.17 Umbilical cord blood contains
stem cells that doctors then transplanted into Molly’s circulatory
system.18 After four weeks, Molly showed bone marrow recovery
and three years later, her immune system was normal.19 The
popular media termed Adam a “savior sibling,” as he was born with
a unique purpose: to save his older sister.20
11. Giuseppe Burgio et al., Conceiving a Hematopoietic Stem Cell Donor:
Twenty-Five Years After our Decision to Save a Child, 97 HAEMATOLOGICA 479,
479–81 (2012).
12. Faison, supra note 1.
13. See id. (“And because both [of Molly’s parents] are carriers for the
disease, there was a whopping 25 percent chance they would have a baby with
[Franconi’s Anemia].”).
14. See Satkiran Grewal et al., Successful Hematopoietic Stem Cell
Transplantation for Fanconi Anemia from An Unaffected HLA-Genotype–
Identical Sibling Selected Using Preimplantation Genetic Diagnosis, 103 BLOOD
1147, 1147, 1150 (2004) (discussing the novelty of “savior siblings” and how it was
Molly’s only viable option).
15. See id. at 1147–48 (describing the process to create a “savior sibling”).
16. Faison, supra note 1.
17. Id.
18. See id. (explaining that umbilical cord blood contains stem cells that are
required to heal Molly).
19. Bruce Dickens, Preimplantation Genetic Diagnosis and ‘Savior Siblings’,
88 INT’L J. GYNECOLOGY & OBSTETRICS 91, 94 (2005).
20. See Kirsty Horsey, US ‘Saviour Siblings’ Spark Debate, IVF.NET (May 5,
2004), https://ivf.net/ivf/us-saviour-siblings-spark-debate-o299.html (naming the
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As the Nash family can attest, advances in reproductive
technology are increasingly finding applications in fields that seem
more the realm of science fiction than reality.21 One such
application is in the treatment of individuals suffering with rare
genetic diseases, who are desperately in need of some form of
biological material transplantation.22
“Savior siblings” is the term used to describe a sibling created
for the purpose of providing biological material that can help treat
or cure an existing terminally ill child.23 These children are
conceived through the sequential use of two reproductive
technologies: pre-implantation genetic diagnosis (PGD) and invitro fertilization (IVF).24 While these techniques were developed
for other purposes, in the context of savior siblings, PGD is used to
screen embryos prior to implantation in the uterus, to determine
whether the embryo will be a tissue “match” to a sick child.25 It is
estimated that roughly one percent of PGD in the United States is
used to create children that are tissue matches for their siblings.26
While the process has become more common in America in
recent years, meaningful discussion about savior siblings has
lagged. The practice has advanced with nearly no governmental
involvement, as there exists no formal regulation or professional
society guidelines governing the use or creation of savior siblings.27
first savior sibling “Adam”) (on file with the Washington & Lee Journal of Civil
Rights & Social Justice).
21. See Alison Motluk, Fertility Treatments: From Sci-Fi to Reality, GLOBE &
MAIL (Feb. 9, 2015), https://www.theglobeandmail.com/life/health-and-fitness/hea
lth/a-look-inside-the-changing-world-of-fertility/article22863038/ (describing how
advanced reproductive technology is today) (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
22. See Horsey, supra note 20 (explaining that tissue transplants from
“savior siblings” had been used to treat several types of leukemia and anemia).
23. See id. (noting that “savior siblings” are used to help treat terminally ill
siblings via biological donations).
24. See Faison, supra note 1 (describing the process by which “savior
siblings” are conceived).
25. See id. (explaining how PGD is used to screen embryos for a specific
tissue match).
26. See BETH WHITEHOUSE, THE MATCH: SAVIOR SIBLINGS AND ONE FAMILY’S
BATTLE TO HEAL THEIR DAUGHTER 127 (2001) (stating the percent of PGD uses
that correspond with “savior siblings”).
27. See Michelle J. Bayefsky, Comparative Preimplantation Genetic
Diagnosis Policy in Europe and the USA and Its Implications for Reproductive
Tourism, 3 REPROD. BIOMEDICINE & SOC’Y ONLINE 41, 43–45 (2016) (discussing
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The case of the United States stands in stark contrast to other
countries, particularly the United Kingdom, where a robust
regulatory framework for the use of savior siblings has risen, along
with debate and discussion over the acceptability of savior
siblings.28
The issue of savior siblings is fraught with ethical pitfalls.29
Thus, extraordinary care and planning must be invested to ensure
that the process is undertaken only when absolutely necessary and
is done in a way that respects the dignity of the new child.30
Protection of dignity and preservation of autonomy are
fundamental tenets in bioethics, and must be kept in mind,
especially when dealing with a vulnerable population, such as
children.31 Caution is paramount, as there is potential for serious
ethical missteps. For instance, some hypothesize that the savior
sibling may be irrevocably harmed by being a savior, if the child
believes that they were not wanted for themselves, or if a child
conceived for this reason enjoys a less close and loving relationship
with his/her parents.32 Opponents of this practice go so far as to
suggest that no matter how the parents choose to love and care for
the new child, it still does not ameliorate the harm caused by the
fact that this child may be aware that they were born for the
purpose of saving their sibling.33 These potential harms contrast
the lack of regulation regarding PGD in the United States).
28. See id. (comparing the regulation of the United Kingdom with the lack of
regulation in the United States).
29. See Grewal et al., supra note 14 (listing several ethical issues regarding
savior siblings).
30. See Thomas R. McCormick, Principles of Bioethics, UNIV. WASH. SCH.
MED., https://depts. washington.edu/bioethx/tools/princpl.html (last updated Oct.
1, 2013) (describing the “[f]our commonly accepted principles of health care
ethics . . . include[ing] the: principal of respect for autonomy, . . . of
nonmaleficence . . . of beneficence, and . . . justice” implicated by savior siblings)
(on file with the Washington & Lee Journal of Civil Rights & Social Justice).
31. See Grewal et al., supra note 14 (describing ethical issues regarding
savior siblings).
32. See Jennifer Lahl, My Sister’s Savior, CBC (July 22, 2009), http://www.
cbc-network.org/2009/07/my-sisters-savior/ (describing the argument that savior
siblings will be irrevocably harmed by being a savior sibling) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
33. See Alasdair Cochrane, Undignified Bioethics, 24 BIOETHICS 234, 235–38
(2010) (stating the various arguments that dignity should play a major role in
bioethics).
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with the therapeutic benefits that having a savior sibling can
provide, both for the existing sick child, who gets to continue living,
and the family unit as a whole, who not only do not have to bury a
child, but now have the enjoyment of two (hopefully healthy)
children. Consideration of savior siblings is a necessary endeavor
for those at the intersection of law and bioethics, as this process
raises a number of issues that can benefit from the input of those
with an understanding, not only of bioethical principles, but of
legal issues concerning child autonomy, welfare, and pediatric
consent.34
This Article will approach the topic of savior siblings, created
using pre-implantation genetic diagnosis and in-vitro fertilization,
from an ethical and legal focus. It will start with an investigation
into the nature and technology surrounding the creation of savior
siblings. The next section will move into a discussion about the
unique ethical issues presented by savior siblings. Then, the
regulatory framework (or lack thereof) that governs their use will
be addressed, contrasting the lack of regulation in the United
States, with the framework in the United Kingdom, where the use
of savior siblings is regulated. This Article will conclude with a
series of practical recommendations, including a call for regulation
in the United States, in order to move the field forward ethically,
and responsibly.
II. What is a savior sibling?
Most of the conditions that savior siblings are used to
ameliorate are genetic in nature.35 Pre-implantation genetic
diagnosis (PGD) refers to the genetic profiling of embryos, and is
used to screen embryos and zygotes for genetic diseases.36 In PGD,
34. See generally Zachary E. Shapiro, FIELD NOTES: BIOETHICS IN THE LAW,
47 HASTINGS CTR. REP. 1 (2017).
35. See Horsey, supra note 20 (explaining that savior siblings are used to
help treat terminally ill siblings via biological donations).
36. See Molina B. Dayal et al., Preimplantation Genetic Diagnosis,
MEDSCAPE,
https://emedicine.medscape.com/article/273415-overview
(last
updated Dec. 30, 2015) (“[PGD] refers specifically to when one or both genetic
parents has a known genetic abnormality and testing is performed on an embryo
to determine if it also carries a genetic abnormality.”) (on file with the Washington
& Lee Journal of Civil Rights & Social Justice).
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a biopsy is taken from an embryo that has been artificially
fertilized outside of a woman’s womb.37 This biopsy then undergoes
genetic analysis, in order to determine genetic makeup of the
embryo, with respect to the disorder in question.38
Given that PGD requires a biopsy, it is an invasive procedure
that carries small, but real, risks to the embryo.39 While most of
the risks come from improper biopsy technique, the risks are real.40
Most medical practitioners therefore feel that PGD is only
warranted if there is a necessary indication for its use.41
PGD is undertaken when creating a savior sibling for two
reasons. First, it is important that the new child does not suffer
the same disease as the existing child, as a sick child cannot serve
as a donor, and could face the same health problem as their older
sibling.42 Second, it is essential that the new sibling be a tissue (or
HLA) match with their older sibling, so that the child can
successfully donate biological material without fear of said
material being rejected.43 Even close relatives and siblings are
often not a genetic match, meaning they would be unable to donate
biological material.44 When a donor is not a match, the recipient’s

37. Id.
38. See id. (explaining that in PGD the embryo is tested to determine if it is
afflicted with a genetic disorder).
39. See Embryo Freezing (Cryopreservation), GENETICS IVF INST.,
http://www.givf.com/fertility/embryofreezing.shtml (last visited Apr. 17, 2018)
(indicating there are risks to the embryo in performing PGD) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
40. See Bust a Myth about PGD/PGS, FERTILITY AUTHORITY,
http://www.fertilityauthority.com/articles/bust-myth-about-pgd-pgs (last visited
Apr. 17, 2018) (indicating that not everyone should use PGD as it contains
dangers for the embryo) (on file with the Washington & Lee Journal of Civil
Rights & Social Justice).
41. See id. (listing the most common indications for PGD’s use are
pregnancies in women thirty-nine and older, severe male factor infertility, two or
more past miscarriages, and past IVF failures).
42. See Merle Spriggs, Is Conceiving a Child to Benefit Another Against the
Interests of the New Child?, 31 J. MED. ETHICS 341, 341–42 (2005) (explaining
that PGD can lower the odds that the savior sibling suffers from the same disease
as the afflicted child).
43. See id. (stating that PGD can be used to tissue match the savior sibling
with the afflicted child).
44. See HLA Matching, supra note 9 (noting that siblings only have a 25%
chance of being a tissue match for each other).
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immune system rejects the transplantation.45 It is also possible for
the donated biological material to “reject” the host into whom it
has been transplanted, causing a serious reaction called graft vs.
host disease.46 Thus, PGD is required to ensure not only that the
new child will be free from the disease, but will also be a tissue
match with the sick child.
Of course, the concept of savior siblings does not necessarily
require the use of in vitro fertilization, as a couple could conceive
naturally.47 Such parents would have to hope that they bear a new
child who is not afflicted by the condition of their sibling, and hope
that the new child will be a tissue match with the existing child.48
In these circumstances, conceiving naturally carries a significant
risk, that either the baby will be born into a life of suffering and
pain, or that complications could arise during pregnancy, which
could threaten the life or well-being of the mother.49 The concept of
savior siblings need not be restricted to siblings. Indeed, a child
could be conceived to help cure a sick parent, relative, or other
member of the family, a concept that will be discussed further
below.50 Typically, the use of in vitro fertilization and PGD is
necessary for the creation of savior siblings due to the need to
match donor tissue matching with the existing sick child.51
45. See Transfusion Reaction—Hemolytic, U.S. NAT’L LIB. MEDICINE, https://
medlineplus.gov/ency/article/001303.htm (last visited Apr. 17, 2018) (describing
how non-matching biological donations cause the host to reject the transfusion)
(on file with the Washington & Lee Journal of Civil Rights & Social Justice).
46. See Graft vs Host Disease: An Overview in Bone Marrow Transplant,
CLEV. CLINIC, https://my.clevelandclinic.org/health/diseases/10255-graft-vs-hostdisease-an-overview-in-bone-marrow-transplant (last updated Apr. 17, 2014)
(explaining that in Graft vs. Host Disease “the donated bone marrow or peripheral
blood stem cells view the recipient’s body as foreign, and the donated cells/bone
marrow attack the body”) (on file with the Washington & Lee Journal of Civil
Rights & Social Justice).
47. Janelle Mills, Understanding the Position of the Savior Sibling: Can We
Save Lives and Protect Savior Siblings, WAKE FOREST U. GRADUATE SCH. ARTS &
SCI., at ix (Dec. 2013), https://wakespace.lib.wfu.edu/bitstream/handle/10339/391
13/Mills_wfu_0248M_10493.pdf (on file with the Washington & Lee Journal of
Civil Rights & Social Justice).
48. See id. at 2 (discussing the risks associated with having a child naturally,
specifically, that the fetus may have the same illness as the sick child).
49. Id.
50. See infra C. Slippery Slope(analyzing “slippery slope” arguments and
ways in which the “savior siblings” process could be abused).
51. See generally S. Sheldon & S. Wilkinson, Should Selecting Savior
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A. When are savior siblings considered?
The decision to create a savior sibling is by no means common.
This section will discuss conditions for which savior siblings might
be a plausible treatment, and point out ethical implications of
these conditions. Consideration of savior siblings is only
biologically appropriate under a specific set of circumstances.52
First of all, the disease affecting the sick individual must have
some genetic component or be readily identifiable with genetic
testing.53 This is important because, as mentioned above, it is
essential that the savior does not suffer the same condition as the
sick child.54 While pre-implantation diagnosis is an evolving and
advancing field, we currently only have the ability to perform
genetic testing on an embryo for a select list of genetic conditions.55
These conditions are the only ones that we can currently ensure,
through screening, will not be present in the savior embryo, prior
to implantation.56
Secondly, savior siblings should only be considered when a
child is suffering from a disease that is serious enough to
necessitate intervention, but which can only be treated through
the use of transplantation.57 Most savior siblings have been
employed to ameliorate life-threatening conditions, both genetic

Siblings be Banned?, 30 J. MED. ETHICS 533, 537 (2004) (arguing that “the
selection of saviour siblings should be permitted, especially given that prohibiting
it would result in the preventable deaths of a number of existing children”).
52. Bruce Dickens, Preimplantation Genetic Diagnosis and ‘Savior Siblings’,
88 INT’L J. GYNECOLOGY & OBSTETRICS, 91, 92–94 (2005).
53. See id. (outlining the elements of pre-implantation genetic diagnosis); see
also Dayal et al., supra note 36 (explaining the science behind pre-implantation
genetic diagnosis).
54. See id. (explaining that only unaffected embryos are transplanted as to
avoid replicating the genetic disorder).
55. See PGD Testable Diseases, THE FERTILITY INSTITUTE, http://www.
fertility-docs.com/programs-and-services/pgd-screening/genetic-diseases-testedfor-with-pgd.php (last visited Apr. 17, 2018) (advertising the Fertility Institute’s
ability to screen for over 400 hereditary diseases during the embryo stage) (on file
with Washington & Lee Journal of Civil Rights & Social Justice).
56. Id.
57. See Dickens, supra note 52, at 93–96 (outlining the policy concerns
considered by a handful of countries in the debate over the use of pre-implantation
genetic diagnosis).
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and otherwise.58 This Article does not categorically suggest that
savior siblings should not be used to provide transplantations for
elective procedures, or procedures that will simply improve quality
of life. However, if there is no life-threatening condition being
suffered, it is much more difficult to ethically justify the creation
of a savior child.59 While most of my analysis focuses on savior
siblings used to treat debilitating and generally fatal conditions
that are not curable through other means, the potential for abuse
in this regard will be discussed later, as it provides support for
seeking some form of regulation of this procedure.
Savior siblings provide biological material, so any disease that
could be treated through a transplant, could theoretically be
treated by means of a savior sibling.60 While transplantation
immediately conjures images of organ harvesting, it can actually
refer to a broad range of biological material transplantation, with
organs perhaps being the rarest material harvested.61 Up to this
point, savior siblings have been utilized to treat conditions that can
be cured through the transplantation of hematopoietic stem cells,
derived from bone marrow, umbilical cord blood, or peripheral
blood.62 Nonetheless, this technology and practice could easily be
utilized to harvest a more significant donation, such as a kidney or
another organ, which would have troubling implications.63

58. See id. (describing several high-profile uses of pre-implantation genetic
diagnosis by families due to the serious and life-threatening nature of disease
experienced by a child).
59. See id. at 95 (addressing many of the ethical issues which challenge the
use of pre-implantation genetic diagnosis and other reproductive technologies).
60. Id.
61. See Todd Pesavento, Facing Organ Donor Shortage, Patients Forced to
Get Creative, LIVESCIENCE.COM (Oct. 20, 2015), http://www.livescience.com/
52526-rarity-of- organ-donations-forcing-patients-to-get-creative.html (reporting
on the unconventional ways patients have attempted to circumvent the shortage
of organ donations available for transplantation) (on file with Washington & Lee
Journal of Civil Rights & Social Justice).
62. See Susan M. Wolf et al., Using Preimplantation Genetic Diagnosis to
Create a Stem Cell Donor: Issues, Guidelines & Limits, 31 J. L. MED. & ETHICS
327, 329–35 (2003) (outlining the ways in which stem cells from savior siblings
have provided important biological material).
63. See id. at 334 (recommending a framework that requires judicial review
of bone marrow and solid organ transplant “to determine whether the harvest is
in the best interest of the donor child”).
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Hematopoietic stem cell transplant can be used to combat an
evolving list of diseases, but is most often associated with fighting
cancers of the blood and bone marrow.64 These range from
commonly known conditions like leukemia, Hodgkin’s and NonHodgkin’s Lymphoma, and solid tumor cancers, to certain
hematologic diseases (non-cancerous blood diseases) and metabolic
conditions.65
Thirdly, consideration of a savior sibling should only occur
when there is no viable tissue donor that can be found for the sick
child.66 While “transplantation from an HLA identical sibling is
associated with a much higher success rate than a transplant from
alternative donors,”67 an existing tissue match renders the creation
of a savior sibling unnecessary.68 The presence of an existing donor
eliminates the ethical quandaries raised by the creation of savior
siblings, discussed below. Furthermore, an older, more developed
person has more biological material to donate, especially when
compared to a very young child who may not be fully developed in
key aspects.69
Finally, the condition that requires transplantation must not
be immediately life threatening, as it can take several years for a
savior sibling to be able to provide the necessary biological

64. See Ajay Perumbeti, Hematopoietic Stem Cell Transplantation,
MEDSCAPE (Nov. 13, 2017), http://emedicine.medscape.com/article/208954overview (discussing the biological mechanisms of hematopoietic stem cell
transplantation (HSCT) and medical indications for HSCT treatment) (on file
with Washington & Lee Journal of Civil Rights & Social Justice).
65. Id.
66. See G.N. Samuel et al., Establishing the Role of Pre-Implantation Genetic
Diagnosis with Human Leucocyte Antigen Typing: What Place do “Saviour
Siblings” have in Paediatric Transplantation?, 94 ARCH. DIS. CHILDHOOD 317,
318–20 (2009) (“Discussions regarding this technology may be appropriate where
no suitable related donor is available and transplantation is only likely to be
entertained with a matched sibling donor.”).
67. See Katrien Devolder, Preimplantation HLA Typing: Having Children to
Save our Loved Ones, 31 J. MED. ETHICS 582, 582 (2005) (addressing critics of preimplantation tissue typing as a method of ensuring that potential donor children
are a tissue match).
68. See id. at 583–88 (“The underlying reasoning is that when PGD is used
to test for genetic diseases that testing is done in the best interests of the embryo
or the person it will become, whereas when PGD is used solely for tissue typing,
the only benefit is for the existing sick child.”).
69. See generally Samuel et al., supra note 66.
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material to the sick child.70 The amount of time before a savior
sibling can provide material to treat a child varies depending on
exactly what material is needed.71 In the case where the umbilical
cord would provide sufficient stem cells, the cure can be harvested
immediately after birth, with no further requirement from the
savior sibling.72 In cases where bone marrow or some other
material are needed however, it can be several years before a
savior sibling can function as a viable donor.73
While potential for abuse exists, a strict analysis of conditions
where consideration of savior siblings would be appropriate is of
utmost importance. These conditions combine to make the use of
savior siblings, objectively quite rare.
III. Ethics
The ethical issues raised by savior siblings vary and depend
on the type of transplantation required.74 Many believe that the
ethical questions exist on a spectrum, reflecting the invasiveness
of the tissue being transplanted.75 This spectrum views noninvasive transplantation, such as the use of umbilical cord blood,
as less objectionable than a more extensive procedure, such as the
donation of bone marrow, and these procedures similarly being less
objectionable than a permanent donation such as a kidney or
another vital organ.76 No matter the degree of invasiveness, there
are a few key arguments advanced in nearly any framework
dealing with savior siblings.

70. See id. at 319 (explaining that IVF and PGD for HLA typing with the
goal of one day performing a biological material donation is only appropriate in
non-urgent transplantation cases).
71. Id. at 319.
72. Id. at 319.
73. See generally Devolder, supra note 67, at 585 (noting how age is a factor
in bone marrow donations).
74. See id. at 584 (discussing the ethical issues raised by various
transplantation procedures).
75. See id. (discussing the range of acceptability of donor transplantations
from the “widely accepted” umbilical cord blood harvest to the “not accepted” vital
organ harvest).
76. Id.
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A. Concerns about the New Child
Many of the ethical arguments against the use of savior
siblings focus on the status and welfare of the newly conceived
child.77 One specific concern relates to commodification of the
savior sibling. In a procedure such as tissue donation, it is difficult
to argue that the savior sibling is not, in some way, being used as
a means (providing a cure) to an end (curing an existing sick
child).78 Many philosophers, particularly Kantians,79 will object on
this basis. One could respond that while the savior sibling is being
used a means, it is not merely a means to an end. Indeed, a savior
sibling serves a much more complicated role: that of a savior, a
family member, and an individual person. Of course, worries of
commodification must be addressed, as without the savior sibling’s
role of providing biological material that allows for the curing of a
sick child, it is unlikely that this specific individual would exist.
This is because a great deal of effort and technology must be
invested to ensure that the new child meets the specific conditions
necessary to serve as a donor (namely that they are free from the
disease, and are an HLA match with the existing sibling).
The commodification argument plays into the larger
contention that being used as a savior sibling damages the welfare
of the new child.80 Some argue that the new child may feel like they
only exist to serve their sick sibling, as a simple cog in the family
machine that decided to create them.81 This could lead to feelings
77. See Sally Sheldon & Stephen Wilkinson, ‘Saviour Siblings’: Hashmi and
Whitaker. An Unjustifiable and Misguided Distinction, PROCHOICEFORUM (2005),
http://www.prochoiceforum.org.uk/irl_rep_tech_2.asp#top (outlining the ethical
controversies surrounding savior siblings as presented in two cases decided by
the Human Fertilisation and Embryology Authority) (on file with author).
78. See generally Jose Silber, Is it Ethical to Have a Child to Save a Child?,
13 AAP GRAND ROUNDS 30, 30 (2005).
79. Id.
80. See Mariana Do Carmo, Child Autonomy and the Rights to One’s Own
Body: PGD and Parental Decision Making, THEBIOETHICSPROJECT (Feb. 13,
2013), http://www.thebioethicsproject.org/essays/child-autonomy-and-the-rightsto-ones-own-body-pgd-and-parental-decision-making/
(discussing
ethical
considerations of savior siblings as related to the wellbeing of the child) (on file
with author).
81. See, e.g., Allane Madanamoothoo, Saviour-Sibling and the Psychological,
Ethical and Judicial Issues that It Creates: Should English and French
Legislators Close the Pandora’s Box?, 18 EUR. J. HEALTH L. 293, 301 (2011)
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of depression and a lack of self-worth or malaise, as the child may
not feel special in their own right, but rather that they are forever
tied to their sibling.82 It has been argued that serving as a savior
sibling solely benefits the parents and sick child, as the savior may
be subjected to invasive, and potentially painful, procedures that
provide no direct biological benefit to them as an individual.83
Indeed, while many of these procedures are simple, some of them,
such as bone marrow transplant, can be extremely painful.84
These concerns become even starker when parents wish to
undertake a more significant transplantation from a savior
sibling.85 While utilizing the umbilical cord that is otherwise
discarded may be morally acceptable, there is greater risk if
saviors were to donate biological materials such as organs or other
tissues.86 Harvesting an organ can result in a lifetime of
differentiated care and health problems, including the possibility
of a shortened life span.87 With no obvious benefit to the new child,
(“[T]hey may feel of having been conceived for the sole purpose of caring for their
elder brother or sister.”).
82. See Sally Sheldon & Stephen Wilkinson, Should Selecting Saviour
Siblings Be Banned?, 30 J. MED. ETHICS 533, 534 (2004); see also Savior Siblings:
At What Moral Cost?, ZENIT (Mar. 23, 2011), http://zenit.org/articles/saviorsiblings-at-what-moral-cost/ (concluding that selecting savior siblings should not
be banned) (on file with the Washington & Lee Journal of Civil Rights & Social
Justice).
83. See generally LORI KNOWLES & GREGORY E. KAEBNICK, REPROGENETICS:
LAW, POLICY, AND ETHICAL ISSUES (2007) (bringing together bioethicists from the
United States, Canada, and the United Kingdom to examine the ethical and policy
questions created by new genetic technologies).
84. See, e.g., Martha Bebinger, From Cheek Swab To Operating Room:
What’s It Really Like To Donate Bone Marrow?, WBUR (May 13, 2014),
http://commonhealth.wbur.org/2014/05/what-its-like-to-donate-bone-marrow
(highlighting David Cavell’s journey of donating bone marrow) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
85. See, e.g., Risks Involved in Living Donation, KIDNEYLINK, http://www.
kidneylink.org/RisksInvolvedinLivingDonation.aspx (last visited Apr. 17, 2018)
(discussing risks associated with kidney donation, including: high blood pressure,
the kidney not functioning properly after recipient receives the transplant,
unforeseen problems the donor may experience, body image problems from the
surgical scars, and feelings of anger or anxiety) (on file with the Washington &
Lee Journal of Civil Rights & Social Justice).
86. See id. (explaining the dangers that savior siblings face in donating
certain organs).
87. See id. (emphasizing the long-term risks associated with savior siblings
donating organs).
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there seems to be a clear difference if a savior sibling is created for
a donation more invasive than bone marrow, as such a process
disregards the welfare of the savior, in favor of the health of the
sick child and the happiness of the family unit.
Invasive donation is particularly problematic, given that the
savior sibling is not afforded the same level of autonomy that a
normal individual is given when deciding to consent to a
transplant of biological material.88 It is important to note that
autonomy is necessary for an individual to give consent to a
procedure.89 Autonomy can be violated through coercion or
pressure, which removes an individual’s ability to give genuine
consent, or by not providing an individual with the option of
consenting.90
Savior siblings present a unique situation with the issues of
consent and autonomy for several reasons. Firstly, as the child was
created specifically to serve as a donor, the individual does not
have the chance to “agree” to serve as a savior sibling.91 This means
that the only wishes that get expressed, when deciding whether or
not to create a savior sibling, are those of the parents.92 Some argue
that this fundamentally undermines the ability of that individual
to ever give meaningful consent, as they were created for the
purpose of serving as a transplant, whether they want to or not.93

88. See Kimberly Strong et al., Savior Siblings, Parenting and the Moral
Valorization of Children, 28 BIOETHICS J. 187, 188–90 (2014) (testing the ethical
objection to savior siblings and concluding that the ethical objections rely heavily
on speculative arguments and inappropriately scrutinize parental motives).
89. See K. Satyanarayana Rao, Informed Consent: An Ethical Obligation or
Legal Compulsion?, 1 J. CUTANEOUS AESTHETIC SURGERY 33, 33–35 (2008)
(claiming that informed consent is an ethical and legal obligation).
90. See id. (asserting that no one has the right to coerce the patient to act in
any way, not even a doctor).
91. See Kiley Bonk, Minors as Living Organ Donors: Protecting Minors from
Martyrdom, 28 CHILD. LEGAL RTS. J. 45, 45 (2008) (considering the legal
safeguards in place with regard to organ donation by minors and discussing the
possible side effects).
92. See id. (discussing the inability of savior siblings to consent to their role
in the savior sibling process).
93. See Steven Ertelt, Rescue Me: The Moral and Ethical Problems of
Creating Savior Siblings, LIFENEWS (Aug. 8, 2008), http://www.lifenews.com/2008
/08/08/bio-2540/ (discussing ethical issues with savior siblings and consent) (on
file with Washington and Lee Journal of Civil Rights & Social Justice).
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Some scholars question whether consent from the savior
sibling is even factored in to the decision to harvest biological
material in the first place.94 In many cases, the child may be too
young to have the capacity to offer their own consent.95 There are
several levels of concern regarding consent that relate to the
invasiveness of the proposed procedure.96 To wit, it is probably not
very important that we obtain a newborn’s “consent” to use their
umbilical cord, which is arguably considered a part of the mother
anyway, and is traditionally discarded.97 But if the procedure
involves significant pain, or a potentially life-long alteration of the
savior sibling’s quality of life, one would agree that then it becomes
more important to have the consent of the individual.
Scholars question whether savior siblings will face undue
pressure from their family unit, meaning that even if they chose to
serve as donors, this may not be a genuinely autonomous choice.98
Undue pressure can remove a normal individual’s ability to
consent to a procedure, to say nothing of a young child.99 Even with
supportive parents, children may feel compelled to fulfill their
family’s wishes, and feel a sense of responsibility for their sibling’s
life, which only they are able to “save.”100

94. See generally KNOWLES & KAEBNICK, supra note 83, at 187–89
(considering the benefits and risks of combining reproductive technologies).
95. See Lawrence Schlam & Joseph Wood, Informed Consent to the Medical
Treatment of Minors: Law and Practice, 10 HEALTH MATRIX: J. LAW-MED. 141, 142
(2000) (analyzing the competence of minors and discussing the requirement of
informed consent when treating minors).
96. See id. (discussing the different ethical questions involved in medical
decisions for minors).
97. See Donating Umbilical Cord Blood to a Public Bank, HEALTH
RESOURCES & SERVS. ADMIN., https://bloodcell.transplant.hrsa.gov/cord/options/d
onating/index.html (last visited Apr. 17, 2018) (explaining the process of
donating umbilical cord blood and how the umbilical cord is typically discarded)
(on file with the Washington & Lee Journal of Civil Rights & Social Justice).
98. See, e.g., Strong et al., supra note 88, at 187–89 (discussing the moral
significance and pressures from the parents of a savior sibling).
99. See, e.g., Cameron Stewart & Andrew Lynch, Undue Influence, Consent
and Medical Treatment, 96 J. ROYAL SOC’Y MED. 598, 599 (2003) (explaining the
influence of the doctor-patient relationship when consenting to medical
treatment).
100. See id. (providing an example of a child who felt responsible for the life
of their sibling).
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Superimposed on the issue of consent specific to the savior
sibling situation is the more general issue of informed consent in
children. Young children generally lack a true understanding of
medical procedures and what they entail.101 A full discussion of
this is beyond the scope of this Article, but the issue clearly imparts
an ethical consideration.
While some highlight the magnitude of such ethical pitfalls,102
other scholars argue that creating savior siblings may not lead to
the negative scenarios imagined.103 These scholars point out that,
when considering ethical objections to the creation of a savior
sibling, we must do our best to try to assess what effect being a
savior sibling has on a child to determine whether the fears and
concerns that people raise are well founded, or alarmist.104
B. Available Data
While the arguments raised above seem persuasive, there is
currently little direct evidence to back up claims that being a savior
sibling is damaging to the welfare, psychological or emotional
health of the savior sibling.105 It is essential to note, that this
evidence is lacking, primarily because of the novelty of the
procedure, and the absence of serious, long-term investigation.106

101. See id. at 600–04 (discussing the influence of family members on a child’s
decision making abilities).
102. See, e.g., Wesley J. Smith, “Savior Siblings” Start Us Down Harrowing
Ethical Path, CENTER FOR BIOETHICS & CULTURE (Mar. 3, 2011), http://www.cbcnetwork.org/2011/03/savior-siblings-start-us-down-harrowing-ethical-path/
(criticizing the creation of a savior siblings) (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
103. See, e.g., Guido Pennings, Saviour Siblings: Using Preimplantation
Genetic Diagnosis for Tissue Typing, 1266 INT’L CONG. SERIES 311, 312–17 (2004)
(weighing ethical concerns regarding savior siblings).
104. See id. (discussing the need to consider the sensibilities of the savior
sibling in their creation).
105. See Sheldon & Wilkinson, supra note 51, at 534 (finding that arguments
against the practice of savior siblings based on the welfare of the savior sibling
are unfounded).
106. See id. at 536 (“[F]ull consideration of the issue of psychological harm
would involve marshalling substantial bodies of empirical evidence (not
something that we can do here).”).
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Many have criticized the available quality of life studies as
relying too much on self-reporting,107 and for lacking objective
indices about appropriate quality of life criteria.108 Despite these
flaws, interviews and anecdotal data suggest that many savior
siblings have relatively normal, uncomplicated lives, free from
philosophical concerns about their creation or place in the
universe.109 I argue that parents who undergo the extensive
process needed to have a savior sibling are unlikely to simply
disregard or treat the savior child poorly, just because their
function as a donor is over. Indeed, given the extensive time,
money, effort, and difficulty, involved in having a savior sibling,
the process is unlikely to be undertaken by parents who are not
concerned with caring for their children. It is just as likely that
parents might show increased care for the savior sibling, as the
savior has played an integral role in preserving the family unit.
Further, although there is some argument that psychological
harm could occur if a child finds out that he or she was wanted not
for himself or herself, but rather for the ulterior purpose of
assisting a sibling to live, anecdotal interview data report high
level of satisfaction for the savior sibling.110 This may be due to the
fact that it seems just as likely that that child will feel pride and
contentment in the knowledge that he or she is responsible for
saving the life of a sibling.111 These feelings of pride seem to extend
to the knowledge that the savior was created for a specific purpose.
Interviews with savior siblings also suggest that worries about
commodification, and reason for birth, do not seem to produce
107. See Self-Report Measures: Notoriously Unreliable, INTROPSYCH, http://
www.intropsych.com/ch01_psychology_and_science/self-report_measures.html
(last visited Apr. 17, 2018) (noting the unreliability of studies which collect data
via self-reporting) (on file with the Washington & Lee Journal of Civil Rights &
Social Justice).
108. See Pedro Conceição & Romina Bandura, Measuring Subjective
Wellbeing: A Summary Review of the Literature 2–7 (United Nations Dev.
Programme Dev., Working Paper No. 2, 2008) (finding flaws in the traditional
method of studying quality of life).
109. Telephone Interviews by Zachary Shapiro with various hospitals and
fertility clinics in the United Kingdom (2011–2012) (notes on file with author).
110. See Bonk, supra note 91, at 45–49 (considering the potential
psychological benefits of living organ donation).
111. See generally Grewal et al., supra note 14 (providing an example of a case
wherein a child received psychological benefits).
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serious negative mental and emotional consequences for the savior
sibling.112 Many siblings report not only high levels of personal
pride, and satisfaction, but also a unique feeling of connection with
their sick, older sibling.113
Despite these sanguine reports, there is reason to have
concerns regarding the self-reported experience of savior
siblings.114 Self-reported happiness and quality of life studies have
a long history of subjectivity, and unreliability.115 Given the
novelty of this procedure, there is simply so little primary evidence
that we cannot conclude whether the initial evidence is
generalizable, or whether it is an outlier.116 Indeed, the absence of
evidence showing harm might be meaningless if the data are not
robust.117 Furthermore, research design, implicit bias, and
researcher agenda can have a tremendous impact on social science
research, as can the way in which a question is phrased or the
manner the interview is conducted in.118 These concerns ring
especially true when interviewing children.119
Given the limited amount of data on the savior sibling
experience, it may be helpful to turn to studies of similarly situated
individuals.120 One such study, performed by MacLeod, Whitsett,
Mash, and Pelletier, examined a small number of children who
donated stem cells to their sibling via a painful, but not dangerous,

112. See MacLeod et al., infra note 120 (describing positive mental and
emotional results derived by a savior sibling).
113. See id. (explaining that the savior sibling developed a closer relationship
with his brother as a result of the experience).
114. See generally David Lipinski & Rosemary Nelson, The Reactivity and
Unreliability of Self-Recording, 42 J. CONSULTING & CLINICAL PSYCHOL. 118 (1974)
(arguing that data collected from self-recording is both reactive and unreliable).
115. See id. at 118–19 (summarizing various studies that have addressed the
reliability of self-recording).
116. Id.
117. Id.
118. Id.
119. Id.
120. See Kendra D. MacLeod et al., Pediatric Sibling Donors of Successful and
Unsuccessful Hematopoietic Stem Cell Transplants (HSCT): A Qualitative Study
of Their Psychosocial Experience, 28 J. PEDIATRIC PSYCHOL. 223 (2003) (examining
the psychological impact of pediatric hematopoietic stem cell transplants on
sibling donors and emphasizing the effect on donors involved in unsuccessful
transplants).
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bone marrow biopsy.121 The study contrasted the effects on the
children involved depending on whether the transplant was
successful or unsuccessful.122
There is good reason to believe that these data are meaningful
for the savior sibling situation, as the process of donation is the
same for savior siblings and children who donate biological
material but who were not specifically conceived as savior siblings.
The study found that children who had donated stem cells in a
successful transplant procedure had a generally positive view of
the experience.123 The children reported that the process had many
positive effects on their lives.124 Crucially, investigators noted that
negative feelings of anger, guilt, and blame were present amongst
donors who participated in unsuccessful transplants, or if the
donor child was uninformed about potential medical complications
or did not receive adequate support afterwards.125 This highlights
that donation can be ethically conducted, but should involve honest
discussion with the donor. Furthermore, it highlights that savior
siblings, like any donor children, will need to have a wellestablished support network in place at home.126
In conclusion, lack of evidence of harm to savior siblings does
not mean that harm is not occurring, and further study is essential
before we can draw meaningful conclusions. Study design will be
key in generating effective, longitudinal data. It will be necessary
to assure that the right parties are gathering the evidence, and
that appropriate methodologies are employed. Of course,
researchers must be careful to ensure that any large scale
collection of data is conducted ethically.127 Work should be done to
121. Id. at 225.
122. Id.
123. See id. at 227 (“Nearly all sibling donors who participated in a successful
HSCT believed their participation had a predominantly positive impact on many
life domains, including relationships, view of world, feelings about self and
decreased helplessness, and insight into their sibling’s illness.”).
124. See id. at 227–28 (providing participants’ remarks regarding the positive
impact of a successful HSCT on relationships, views of world, feelings about self
and decreased helplessness, and insight into siblings’ illness).
125. See id. at 228 (discussing themes amongst those involved in unsuccessful
HSCTs, as well as similarities between the unsuccessful and successful groups).
126. See id. (explaining that negative psychological effect as a result of HSCT
most often occurred when the donor did not have adequate emotional support).
127. See generally Ben Berkman et al., The Ethics of Large Scale Genomic

SAVIOR SIBLINGS IN THE UNITED STATES

439

de-identify any sensitive information, along with other appropriate
steps to ensure privacy and protection of data.128 The absence of
such data should lead us to be skeptical of claims which argue that
evidence should push us one way or the other, in this highlycharged field.
C. Slippery Slope
While current uses of savior siblings are limited, a number of
potential troubling ethical issues have been mentioned.129 These
ethical issues may seem benign when applied to an individual case
at this point, but, when taken in aggregate, could pave the road for
troubling practices in the future.130 Indeed, proponents of “slippery
slope” arguments are concerned about discussions regarding savior
siblings and the number of ways in which this process could be
abused.131
The general question is whether any use of savior siblings
paves the way for the potential utilization of savior children for
purposes that society does not find acceptable. This could occur in
two distinct ways. The first concern is that, although savior
siblings are currently used for less invasive donations, such a
process opens up the potential to one day harvest significant
biological material, such as organs, limbs, or tissues, which could
seriously harm the savior sibling, or lead to a compromised quality
of life.132 As discussed above, the ethics surrounding savior siblings
significantly change if the biological material being harvested will
result in a lifetime of differentiated function or care for the
Research, ETHICAL REASONING IN BIG DATA: AN EXPLORATORY ANALYSIS (2015)
(discussing the ethical considerations associated with big data in “biomedical
research settings”).
128. Id.
129. See generally Devolder, supra note 67.
130. See id. (explaining how children do not understand the severe impact and
the consequences of making a donation).
131. See John A. Robertson et al., Conception to Obtain Hematopoietic Stem
Cells, 32 HASTINGS CTR. REP. 34, 34–40 (2002) (discussing concerns about the
donor child’s rights and welfare).
132. See David King, Why We Should Not Permit Embryos to be Selected as
Tissue Donors, in BIOETHICS: AN ANTHOLOGY 158, 158–61 (Helga Kuhse & Peter
Singer eds., 2006) (stating that allowing child donors presents the risk of these
children being treated as objects).
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savior.133 Indeed, donation of any organ, from a kidney, to an eye,
to a lung, would cause a form of permanent harm to the savior
child,134 and might be wholly unacceptable to our society. While
savior siblings are currently primarily used for umbilical cord
blood and bone marrow donations, we must keep in mind this
potential for abuse, so we can safeguard against more intrusive
donations.135
The other slippery slope argument questions whether the
recipients of the donations will one day change, from sick siblings
today to perhaps a parent, elderly family member, or even someone
outside the family unit.136 The prospect of parents using this
mechanism to provide themselves, or other relatives or friends,
with biological material, is rightfully troubling, even to the most
ardent supporters of the savior sibling model.137
Such scenarios raise significant ethical red flags, as this
situation would involve harming a new child, solely for the benefit
of another individual, who lacks the direct connection with the
savior that a sick brother or sister would share. The motivation
behind the decision would also be twisted, as this could present a
scenario where parents decide to have a savior child to save their
own life, or the life of others without an immediate family
connection, complicating our notions of parental decision-making
and autonomy.138
Other objections focus on the notion that IVF and PGD could
be used to usher in a new age of eugenics, as advances allow
parents to select certain traits and favor select characteristics over
133. See Devolder, supra note 67, at 584–85 (discussing how umbilical cord
blood harvest and bone marrow donations are accepted procedures but that
harvesting vital organs is not).
134. See Lainie Friedman Ross & J. Richard Thistlethwaite, Minors as Living
Solid-Organ Donors, 122 PEDIATRICS 454, 455–57 (2008) (examining potential
psychological, medical, and long-term risks to the child donor).
135. See Devolder, supra note 67, at 584 (noting that while umbilical cord
blood harvest and bone marrow donations are widely accepted, the harvesting of
vital organs is not).
136. See id. at 585 (“The second concern of opponents of PGD/HLA typing to
create a donor child is whether this technique should be available when the
intended recipient is someone other than a sibling.”).
137. See id. (discussing a family in the Netherlands, where a father used his
daughter’s umbilical cord blood).
138. See generally King, supra note 132.
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others.139 While there is limited evidence at this juncture, given
the scientific community’s history of problematic utilization,140
such objections should not be dismissed lightly.141 Recognition of
the issues raised in these “slippery slope” arguments should not
lead to a ban on the procedure. They instead argue for the
importance of creating a robust regulatory framework to guide,
and monitor, decision making in this area.
D. Regulation and Decision Making Regarding Savior Siblings
Given the ethical pitfalls discussed above, and the genuine
potential for abuse, the question of who gets to make the decision
about whether to have a savior sibling is complicated. Such a
debate pits traditional arguments of parental rights and autonomy
against arguments concerning the welfare of the savior sibling.142
Ultimately, this leads to the question of whether there is a role for
some form of governmental regulation.
There is a long-standing tradition in the Western World of
allowing parents be the ultimate arbiter of medical and family
planning decisions for their individual family unit.143 These ideals
clash with arguments about the welfare of the child, if there is a
perception that the family is either disregarding a child in a
139. See generally Armand Marie Leroi, The Future of Neo-Eugenics. Now
That Many People Approve the Elimination of Certain Genetically Defective
Fetuses, Is Society Closer to Screening All Fetuses for All Known Mutations?, 7
EMBO REP. 1184, 1184–85 (2006) (arguing that there might be less resistance in
the future to more sophisticated methods of eugenic selection).
140. See generally Michael J. Malinowski, Choosing the Genetic Makeup of
Children: Our Eugenics Past-Present, and Future?, 36 CONN. L. REV. 125, 134–49
(2003) (discussing the origins of eugenics, how the Nazi state used it as a
rationalization for selective breeding, sterilization, and human experimentation,
and the history of the development of eugenics in the United States).
141. See Hilary White, Eugenics Threat Growing in IVF Industry: British
fertility expert, LIFESITENEWS (Apr. 8, 2013), https://www.lifesitenews.com/news/
eugenics-threat-growing-in-ivf-industry-british-fertility-expert (quoting Lord
Robert Winston as saying that “[w]e may find that people well want to modify
their children, enhance their intelligence, their strength and their beauty and all
the other so-called desirable traits”) (on file with the Washington & Lee Journal
of Civil Rights & Social Justice).
142. See Do Carmo, supra note 80 (discussing the tension between a potential
savior child’s rights and parental rights).
143. Id.
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harmful way, or making a decision that flies in the face of
traditional notions of morality.144 Both of these fears are present
when discussing savior siblings, as not only do many believe that
the procedure disregards (and is perhaps, contrary to) the welfare
of the savior sibling, but also the process seems to eschew
traditional conceptions of family morality and planning.145 Indeed,
rarely are the reasons behind having a second child as transparent
and tangible as they are in the case of savior siblings.
Regarding objections concerning the motivation of parents
who decide to have a savior sibling, there are a myriad of motives
commonly accepted as acceptable for family planning.146 While
they may not be as transparent as the decision to have a savior
sibling, they often come with far less genuine good as a result.
Parents have children to create an heir, continue a legacy, serve as
a playmate for a child, strengthen a relationship (or even save a
marriage), or to fulfill another, inherently selfish, desire of the
parents.147 While a variety of these decisions may be frowned upon,
there is no suggestion that parenting should be restricted only to
those who have a “good reason” to conceive.148
Contrasting these cases with the decision to create a savior
sibling, there is actually a great deal of genuine good that comes in
the latter case, as an existing child is able to continue living, and
the family unit does not have to suffer the devastating
consequences of losing a child.149 While it is newer, creating a
savior sibling may not be a “worse” reason for having a child then
our traditionally selfish motives.150 Furthermore, questioning
birth motives could open up Pandora’s Box concerning whether
society, or governments, should have a role in deciding which
reasons are acceptable for birth, and which are not.
The case of savior siblings is one in which the upmost caution
is warranted, making it difficult to argue that there should be no
144. Id.
145. Id.
146. See Devolder, supra note 67, at 583–84 (listing the various motivations
for having a child).
147. Id.
148. Id.
149. See MacLeod et al., supra note 120, at 227 (“[S]aving my brother’s life
was a really tight thing . . . . [W]e now have closer relations in the family.”).
150. See generally Devloder, supra note 67, at 584–85.
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regulation or oversight of any sort.151 While many might agree that
there are certain, limited circumstances where creating a savior
sibling is ethically defensible, others point out the genuine
potential for abuse in a myriad of avenues.152 As mentioned above,
the ethical calculus for savior siblings changes, depending on
factors such as what disease is being treated, what donation is
being sought, how many procedures the savior will be subjected to,
who is being saved, and other factors.153 The answer to these
questions might change the ethical acceptability of creating a
savior sibling. Leaving this decision to the sole discretion of the
parents or a given fertility clinic is problematic. Such a situation
could allow disparate outcomes for similarly situated individuals,
to say nothing of the potential for harm and abuse for the savior
child.
IV. Regulatory Issues in the United States
Many of the ethical concerns detailed above play out in the
larger debate over whether, and to what extent, society should seek
to regulate the decision-making and issues that arise surrounding
the creation of savior siblings.154 Examining the status of savior
siblings in the U.S. reveals that there is little to no governmental
regulation, nor are there any robust guidelines, standards, or
licensing procedures steering professional organizations that are
involved in the creation of savior siblings.155

151. See Malinowski, supra note 140 (analyzing the history of eugenics and
discussing its abuses).
152. See generally Leroi, supra note 139 (discussing the use of abortion as a
eugenic practice).
153. See generally Devolder, supra note 67.
154. See Aaron R. Fahrenkrog, A Comparison of International Regulation of
Preimplantation Genetic Diagnosis and A Regulatory Suggestion for the United
States, 15 TRANSNAT’L L. & CONTEMP. PROBS. 757, 762–68 (2006) (comparing preimplantation genetic diagnosis regulation in Germany, the United Kingdom,
Japan, and the United States).
155. See id. at 768 (“At present, no U.S. jurisdiction has issued legislation or
guidelines for the regulation of PGD with the exception of New York.”).
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A. Formal and Informal Regulation

There is no governmental regulation or specific legal guidance
on the topic of savior siblings in the U.S.156 Indeed, there are no
federal regulations in the U.S. that deal explicitly with the use of
PGD.157 Because of this, uses of PGD, such as the creation of a
savior sibling, are currently left to the discretion of providers and
patients.158
This lack of regulation avoids governmental interference in
personal choices related to birth, ultimately enabling the scientific
community to continue without guidance or oversight. Scholars
describe this scheme of regulation as “voluntary certification.”159
While the CDC developed a model certification template program
for assisted reproduction clinics and laboratories160 in accordance
with the Fertility Clinic Success Rate and Certification Act of 1992
(Fertility Act),161 discretion was left to individual states as to
whether or not they implement the scheme.162 Partially due to this
flexibility, no state has fully adopted the model program, and
scholars maintain that the sector has been mostly left to selfpolice.163 The guidance does not consider savior children.
Indeed, the only governmental action that may be described
as “regulation” is the ban on federal funding for embryo-related
research.164 Funding is currently only approved for research
conducted on cells derived from embryos less than two weeks old,
156. Id.
157. Id.
158. Id.
159. See Malinowski, supra note 140, at 182 (“The United States federal
regulatory scheme for ART clinics can be summarized as voluntary
certification.”).
160. Implementation of the Fertility Clinic Success Rate and Certification Act
of 1992-A Model Program for the Certification of Embryo Laboratories, 64 Fed.
Reg. 39374 (July 21, 1999).
161. Fertility Clinic Success Rate and Certification Act of 1992, Pub. L. No.
102-493, 106 Stat. 3146 (codified at 42 U.S.C. § 201 (1992)).
162. Malinowski, supra note 140, at 182.
163. See id. (“No state has fully adopted the model program, and the CDC has
contractually outsourced implementation to SART, meaning that the sector has
been left to self-police.”).
164. See id. at 183–84 (“As a clinical service, ART escapes the FDA’s product
groupings, and the federal government has long abstained from funding
embryonic research—thereby further castigating ART to the private sector.”).
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that are left over from infertility treatment, have been frozen and
would otherwise be destroyed, or cells derived from frozen embryos
without destroying the embryos.165 As a result, this means that the
U.S. government does not play a significant role in the process and
regulation of IVF, PGD, or decisions regarding savior siblings.166
While there is no formal government funding, the government
does have a part to play in the complex cycle of assisted
reproduction clinics and therapies.167 For instance, the Center for
Medicare and Medicaid Services (CMS) governs the quality of
laboratories and laboratory personnel.168 The Food and Drug
Administration (FDA) generally regulates genetic tests for
analytical and clinical validity.169 These regulatory bodies do not
have specific guidance regarding savior siblings.170
165. See Comm. on Pediatric Research & Comm. on Bioethics, Human
Embryo Research, 108 AAP NEWS & J. 813, 814, http://pediatrics.aappublications.
org/content/108/3/813 (last updated Nov. 1, 2001) (“Some individuals who go
through the process of in vitro fertilization (potential donors) choose not to
undergo additional embryo transfers and do not wish to have their embryos
donated to other individuals. Such individuals or donors may be willing to donate
their embryos for research.”) (on file with the Washington & Lee Journal of Civil
Rights & Social Justice).
166. See Meena Lal, The Role of the Federal Government in Assisted
Reproductive Technologies, 13 SANTA CLARA HIGH TECH. L. J. 517, 534 (1997)
(“[T]he ACT fails to protect the interested parties of IVF because the Secretary
does not have any power to establish any regulation, standard, or requirement
that has the effect of exercising supervision or control over the practice of
medicine in assisted reproductive technology programs.”).
167. Gutman, infra note 169. See generally Clinical Laboratory Improvement
Amendments (CLIA), CTR. FOR MEDICARE & MEDICAID SERV. [hereinafter Clinical
Laboratory], https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/
index.html ?redirect=/Clia (last updated Apr. 5, 2017) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
168. See generally Clinical Laboratory, supra note 167.
169. See Steven Gutman, The Role of Food and Drug Administration
Regulation of In Vitro Diagnostic Devices—Application to Genetics Testing,
CLINICAL CHEMISTRY (May 1999), http://clinchem.aaccjnls.org/content/45/5/746
(“[G]enetic tests are received and reviewed by the FDA.”) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
170. See Michelle J. Bayefsky, Comparative Preimplantation Genetic
Diagnosis Policy in Europe and the USA and its Implications for Reproductive
Tourism, 3 REPROD. BIOMEDICINE & SOC’Y ONLINE 41, 41 (2016), http://www.
rbmsociety.com/article/S2405-6618(17)30004-7/pdf (“[T]he USA has no
regulations concerning the use of preimplantation genetic diagnosis . . . a
technique employed . . . for a variety of controversial purposes, including . . . [the]
selection [of] ‘saviour siblings’ who can serve as tissue donors for sick relatives.”)
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The lack of formal funding, and governmental regulation, has
several consequences. First, disallowing funding restricts the
gathering of data and information regarding the use and
prevalence of savior siblings.171 The absence of monitoring means
that any harm that could be happening to savior children may
currently go unreported, as there is no system in place to follow-up
on savior families, or chart their long term emotional and physical
health.172 Furthermore, not having formal regulation results in
increased authority for clinics performing PGD to make their own
decisions on the moral and ethical issues discussed above.173
Because each clinic is able to make their own policies, similarly
situated individuals in different locations may have vastly
different options available to them.
B. Professional Guidelines
Given the absence of regulatory schema in the U.S.,
professional guidelines, issued by organizations that might be
expected to consider the status and welfare of savior siblings, can
reveal expert opinion and professional attitudes. While
professional guidelines can give a glimpse into informal rules and
regulations that may influence opinion amongst those who are
informed of the risks and benefits, review of current guidelines
reveal a serious lack of consideration regarding savior siblings as
a whole.174
(on file with Washington & Lee Journal of Civil Rights & Social Justice).
171. See R.M.L. Winston, Does Government Regulation Inhibit Embryonic
Stem Cell Research and Can It Be Effective?, 1 CELL STEM CELL 27, 31–32 (2007)
https://www.sciencedirect.com/science/article/pii/S1934590907000124
(“[F]inancing this work by private initiatives or commercial interests raises
substantial concerns.”) (on file with the Washington & Lee Journal of Civil Rights
& Social Justice).
172. Id.
173. See id. at 32. (“Thirdly, there is anxiety that, with commercial pressure,
clinical translation of basic science work could be undertaken too soon and
without adequate safeguards.”).
174. Ilan Tur-Kaspa & Roohi Jeelani, Clinical Guidelines for IVF with PGD
for HLA Matching, 30 REPROD. BIOMEDICE ONLINE 115, 118 (2015), http://www.
rbmojournal.com/article/S14726483(14)00 582-3/pdf (“[I]n many IVF centers, no
set guidelines have been established, and most healthcare providers are still
unaware of such options or how to introduce them to patients.”) (on file with the
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Groups like the American Society for Reproductive Medicine,
American Congress of Obstetricians and Gynecologists, and
American College of Medical Genetics, which create guidelines
concerning IVF, PGD and other aspects of reproductive medicine
offer little of relevance.175 Their guidelines do not take strong
stances on contested ethical topics. Crucially, these organizations
have yet to take an official stance on savior siblings, and, as a
result, their guidance documents do not address savior siblings in
a robust way.
A non-medical organization that might offer insight is the
Council on Ethical and Judicial Affairs (CEJA).176 While the CEJA
discusses organ donation in general, its analysis concerning “unemancipated minors and legally incompetent adults” donating
organs can apply to savior siblings.177 The CEJA determined that
even though these populations should normally not be considered
as possible organ donors, minors who are capable of understanding
may be considered, provided that they share an emotional

Washington & Lee Journal of Civil Rights & Social Justice).
175. See Preimplantation Genetic Diagnosis: A Discussion of Challenges,
Concerns, and Preliminary Policy Options Related to the Genetic Testing of
Human Embryos, GENETICS & PUB. POL’Y CTR. (2004), https://jscholarship.lib
rary.jhu.edu/bitstream/handle/1774.2/978/PGDDiscussionChallengesConcerns.p
df?sequence=1&isAllowed=y (“Professional guidelines are traditionally
voluntary, although they sometimes are viewed as the standard of care.
Guidelines are more useful when some enforcement mechanism is
contemplated.”) (on file with the Washington & Lee Journal of Civil Rights &
Social Justice); see generally Michelle J. Bayefsky, Comparative Preimplantation
Genetic Diagnosis Policy in Europe and the USA and its Implications for
Reproductive Tourism, 3 REPROD. BIOMEDICINE & SOC’Y ONLINE 41, 41–47 (Dec.
2016), https://www.sciencedirect.com/science/article/pii/S2405661817300047
(discussing the lack of oversight and regulation in the United States in
comparison to Europe and the consequences that could result from continued lack
of regulation) (on file with the Washington & Lee Journal of Civil Rights & Social
Justice).
176. See generally About the Council on Ethical & Judicial Affairs (CEJA),
AM. MED. ASS’N, https://www.ama-assn.org/about-us/about-council-ethical-judic
ial-affairs-ceja (last visited Apr. 17, 2018) (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
177. JOHN W. MCMAHON, NONSIMULTANEOUS, ALTRUISTIC ORGAN DONATION:
CEJA Report 6-I-10, at 5 (2010), https://www.ama-assn.org/sites/default/files
/media-browser/public/aboutama/councils/Council%20Reports/council-on-ethicsand-judicial-affairs/i10-ceja-nonsimultaneous-altruistic-organ-donation.pdf (on
file with the Washington & Lee Journal of Civil Rights & Social Justice).
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connection with the recipient, and have the consent of their
guardian.178
In addition to the minor having cognitive capability, the CEJA
points out that because the parent or guardian providing informed
consent is emotionally attached to the recipient, precautions, such
as obtaining a second opinion from an independent ethics
committee, should be taken.179 The CEJA further states that living
organ donors should consult independent physicians, who are able
to make decisions reflecting their best interests.180 An independent
doctor is especially important in the case of a savior sibling, in
order to help ensure that the child is adequately prepared for what
is to come.181 Such planning will affect how the donor perceives
their situation, both before and after a procedure. Unfortunately,
it does not seem like current mechanisms are in place to ensure
that these criteria are met, before a savior sibling donates
biological material.
V. Savior Siblings in the United Kingdom
The lack of regulation in the U.S. stands in stark contrast to
regulatory schemes found in other countries, in particular the
United Kingdom. In the UK, the government regulates PGD by
requiring a clinic to obtain a license before they can perform the
procedures that create a savior sibling.182 This is not surprising,
178. See id. at 5 (“[M]inors with substantial decision making capability who
agree to serve as donors, with the informed consent of their legal guardians, may
be considered for donation to recipients with whom they are emotionally
connected.”).
179. See id. (“Since minors’ guardians may be emotionally connected to the
organ recipient, when an unemancipated minor agrees to donate, it may be
appropriate to seek advice from another adult trusted by the minor or an
independent body, such as consultation with an ethics committee, pastoral
service, or other counseling resource.”).
180. See id. at 4 (“[E]very donor should be assigned an advocate team that
includes a physician . . . . this team ideally should be as independent as possible
from those caring for the recipient. This can help avoid actual or perceived
conflicts of interest between donors and recipients.”).
181. See id. (“[T]his team ideally should be as independent as possible from
those caring for the recipient. This can help avoid actual or perceived conflicts of
interest between donors and recipients.”).
182. See Bayeski, supra note 170 (“License committees determine whether
new conditions qualify as appropriate medical uses of PGD after reviewing an

SAVIOR SIBLINGS IN THE UNITED STATES

449

given that the UK has a long history of governmental regulation of
the medical field.183 This results in significant government
involvement in many aspects of medical technology, and medical
decision-making. As a result, UK regulators have considered the
position of savior siblings for some time now.184
In the UK, PGD is regulated by the Human Fertilization and
Embryology Act (HFEA).185 This Act186 was enacted in 1990, and
allows for PGD to be performed in order to test for severe genetic
diseases and perform tissue type matching for savior siblings
under strict criteria.187 PGD is allowed for medical purposes
only.188 To determine whether PGD may be allowed, the
government provides a list of criteria. These include that:
(1) the condition of the affected child should be severe or
life- threatening, of a sufficient seriousness to justify the
use of PGD; (2) the embryos conceived in the course of this
treatment should themselves be at risk from the condition
by which the existing child is affected; (3) all other
possibilities of treatment and sources of tissue for the
application submitted by a fertility clinic on behalf of a patient.”).
183. See John H. Raach, English Medical Licensing in the Early Seventeenth
Century, 16 YALE J. BIOL. MED. 267, 270 (1944) (“In the early years of the reign of
Henry VIII, two statutes were passed which had a profound effect on English
medicine and its control for more than three centuries. The first of these statutes
[was] passed in 1511.”).
184. See MacKenna Roberts, UK Parliament Legislates ‘Saviour Sibling’
Treatment, BIONEWS (May 27, 2008), http://www.bionews.org.uk/page_13399.asp
(“UK regulation of ‘saviour siblings’ has a conflicted record since the first UK
application in 2001.”) (on file with the Washington & Lee Journal of Civil Rights
& Social Justice).
185. See Donna M. Gitter, Am I My Brother‘s Keeper? The Use of
Preimplantation Genetic Diagnosis to Create A Donor of Transplantable Stem
Cells for an Older Sibling Suffering from A Genetic Disorder, 13 GEO. MASON L.
REV. 975, 987 (2006) (“[T]he HFEA . . . review[s] both the issue of using PGD and
the additional step of tissue typing to determine if an embryo has tissue
compatible with an existing sibling.”).
186. Human Fertilisation and Embryology Act 1990, c. 37 (Eng.).
187. See Gitter, supra note 185, at 989 (“[T]he HFEA also agreed . . . to permit
PGD with tissue typing.”).
188. See Clinical Commissioning Policy: Pre-implantation Genetic Diagnosis,
NHS COMMISSIONING BOARD (Apr. 2013), https://www.england.nhs.uk/wp-content
/uploads/2013/04/e01-p-a.pdf (“The following uses of the PGD technology are
excluded from this policy: Non medical gender selection e.g. for the purpose of
family balancing. This is illegal in the United Kingdom.”) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
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affected child should have been explored; (4) the
techniques should not be available where the intended
recipient is a parent; (5) the intention should be to take
only cord blood for the purposes of treatment, and not
other tissues or organs; (6) appropriate implications
counseling should be a requirement for couples
undergoing this type of treatment; (7) families should be
encouraged to participate in follow-up studies and, as
with PGD, clinics should provide detailed information
about treatment cycles and their outcomes.189

In 2004, fertility regulators in a specialized court ruled that
the HFEA allows parents to use modern reproductive techniques
to create a savior sibling.190 The existence of this regulation is
particularly significant. Indeed, there is tremendous difficulty in
creating regulation of any topic that is as charged and
controversial as birth.191 The UK tackled this problem by basing
this decision on the product of close consultations between various
groups of stakeholders.192 Discussions with fertility clinics and
bioethicists in the UK, reveal that, when initially considering
policy regarding savior siblings, lawyers, ethicists, scientists,
sociologists, religious leaders, and law makers, were consulted.193
These diverse stakeholders devised commonsense policy on a
controversial topic, which ended up being acceptable to a broad
189. HFEA Confirms That HLA Tissue Typing May Only Take Place When
PGD is Required to Avoid a Serious Genetic Disorder, HUM. FERTILISATION &
EMBRYOLOGY AUTHORITY (Aug. 1, 2002), http://hfeaarchive.uksouth.cloudapp.az
ure.com/www.hfea.gov.uk/935.html (on file with the Washington & Lee Journal
of Civil Rights & Social Justice).
190. See Andy Coghlan, Saviour Sibling Babies Get Green Light, DAILY NEWS
(July 22, 2004), https://www.newscientist.com/article/dn6195-saviour-sibling-bab
ies-get-green-light/ (“Fertility regulators in the UK have ruled that families can
pre-select embryos which could potentially save ill siblings.”) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
191. See “Medicine Babies” or Savior Siblings Ethical Debate, KENNEDY INST.
ETHICS, https://bioethics.georgetown.edu/2016/05/medicine-babies-or-saviour-sibl
ings-ethical-debate/ (last visited on Apr. 23, 2018) (highlighting the controversies
associated in the savior sibling debate) (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
192. Telephone Interviews by Zachary Shapiro with IVF Clinics in London,
Manchester, and Essex (2011–2012) (notes on file with author); Telephone
Interviews by Zachary Shapiro with Fertility Regulators and Lawyers in the UK
involved in the creation of regulations concerning savior siblings (2011–2012)
[hereinafter Telephone Interviews].
193. Id.
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swath of the population.194 This allowed lay people to feel that the
government was appropriately balancing the welfare of children
(both saviors and sick siblings), as well as the values of parental
autonomy and choice.195 Those interviewed suggested that the
interdisciplinary nature of the committees was a major factor that
allowed regulation to be promulgated, even when no national
consensus existed.196
To give the regulation teeth, the HFEA provides for
enforcement of these rules by requiring clinics to apply for a new
license for every new genetic disease that they would like to test
an embryo for.197 This not only allows regulators to monitor clinics
that perform IVF,198 but also enables regulation of embryocentered research and PGD.199 The law is given force by attaching
criminal liability to any person who knowingly or recklessly
provides false or misleading information to obtain a license.200
Punishments for such violations of the Act range from a fine to
imprisonment for up to two years.201
Such regulation provides clear guidelines while making it
easier to study, and control, the use of savior siblings.202 It also
194. Id.
195. Id.
196. Id.
197. See Alicia Ouellette et al., Lessons Across the Pond: Assisted
Reproductive Technology in the United Kingdom and the United States, 31 AM. J.
L. & MED. 419, 428 (2005) (“Section 1 of Schedule 2 specifies that clinics require
a license to create embryos in vitro, store embryos, use human gametes, test
embryos before implantation, implant embryos in a woman, test sperm viability,
or conduct research on human embryos or gametes.”).
198. See Human Fertilisation & Embryology Authority, Fact Sheet 2: About
the HFEA, http://hfeaarchive.uksouth.cloudapp.azure.com/www.hfea.gov.uk/docs
/ToftFactSheet2_AboutHFEA.pdf (last visited on Apr. 5, 2018) (providing a basic
summary of the Human Fertilisation & Embryology Act and outlining its
framework for decision making) (on file with the Washington & Lee Journal of
Civil Rights & Social Justice).
199. See generally id. (explaining how FHEA facilitates further embryo
research).
200. Human Fertilisation and Embryology Act 1990, c. 37, § 3 (Eng.).
201. Id. at § 41(3).
202. Zachary E. Shapiro, Savior Siblings in the United States, HARV. L. BILL
OF HEALTH (Oct. 23, 2014), http://blogs.harvard.edu/billofhealth/2014/10/23/savi
or-siblings-in-the-united-states/ (advocating further discussion of savior siblings
and the need for regulation) (on file with the Washington & Lee Journal of Civil
Rights & Social Justice).
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raises difficult questions about the role of governments in the
birthing and family decisions of their citizens. While there exists
genuine dispute as to whether it is fair to leave such important and
contested questions in the hands of legislators and regulators,
especially when there are no clear or universally accepted answers
regarding these difficult questions, the interdisciplinary approach
to creating the regulation helped build public approval.
VI. Conclusions and Recommendations
The close regulation of savior siblings in the UK offers a stark
contrast to the situation in the U.S.203 In the U.S., the relative
novelty of the procedure, its rarity, the lack of governmental
consideration and regulation, and the divergence in opinions
regarding the fundamental ethical questions that surround it, help
explain why the issue of savior siblings has remained largely in the
shadows, unexamined by the government, or the public at large.204
Despite this general disregard, certain commonsense steps could
be taken to better understand and deal with the unique ethical
dilemmas surrounding savior siblings.
A. The U.S. Can Learn from the Regulatory Framework in the UK
The UK has demonstrated that meaningful regulation
regarding savior siblings is possible, without restricting other
values, such as parental and familial autonomy and dignity, even
in a diverse, pluralistic society, where individuals may not agree
with each other.205 The U.S. should learn from this example, and
seek to emulate it, to the extent feasible. As discussed, the need for
regulation in the U.S. is pressing, given that important ethical
decisions regarding savior siblings are currently left to the
203. See id. (“This stands in stark contrast to other countries, particularly
England, France, and Australia, where a regulatory framework for the use of
savior siblings has arisen along with debate over their acceptability.”).
204. See id. (“There has been little meaningful discussion about savior
siblings in bioethical or legal circles, and there is no formal regulation governing
their use or creation in the United States.”).
205. See Roberts, supra note 184 (explaining how UK’s legislation treats
savior siblings).
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discretion of individual parents and health care providers.206
Indeed, given the lack of regulation in the U.S., the only true
barrier for access is the policies of the particular clinic selected.
This means that adequately resourced parents are able to select
clinics that allow whatever procedures they desire.207
The absence of regulation in the U.S. creates a number of
particularly problematic scenarios for savior siblings. First, it
allows potential harm to savior siblings, by not requiring that
savior children are only utilized in specific scenarios.208 Without
regulation, it is possible that saviors will be utilized for some of the
more problematic scenarios discussed above, such as for more
invasive donations, or to serve as donors to non-immediate family
members. Second, in the absence of regulation, it is difficult to
monitor the long-term outcomes for savior children, to ensure that
they are respected and cared for, and do not face lifetime burdens
due to their biology or status. Indeed, savior children issues can go
unnoticed, as there is no central monitoring system. Even the most
ardent defenders of a free-market system can understand the
desire for some form of regulation, in order to protect the welfare
of these children, who are especially vulnerable.
Governmental regulation, informed by legislative guidance, is
therefore necessary, both to develop workable policy, and to
identify, document, and ameliorate current harms. While courts
have certain checks on these outcomes, the need for a parent (or
child) to bring an actual suit, as well as the uncertainty and
subjectivity inherent in the current judicial standards, mean that
courts are not an ideal mechanism to regulate this kind of practice.
The lack of regulation also creates a situation where, given the
206. See Fahrenkrog, supra notes 154–158 and accompanying text (exploring
the lack of regulation in the U.S. and the issues that arise as a result of it).
207. See James F. Smith, Socioeconomic Disparities in the Use and Success of
Fertility Treatments: Analysis of Data from a Prospective Cohort in the United
States, 96 FERTILITY & STERILITY 95, 99–100 (July 2011), http://www.fertstert.org
/article/S0015-0282(11)00667-4/pdf (studying how income effects the availability
and success rates of fertility services) (on file with the Washington & Lee Journal
of Civil Rights & Social Justice).
208. See Maura Dickey, Who Will Save the Savior Siblings?, HUFFPOST (May
15, 2015), https://www.huffingtonpost.com/maura-dickey/who-will-save-the-savi
or-_b_7276688.html (explaining that without further regulation, savior siblings
could be used in an ethically questionable manner) (on file with the Washington
& Lee Journal of Civil Rights & Social Justice).
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great variety of state law and cultural attitudes towards a practice
like savior siblings, similarly situated individuals in different
geographic contexts may have vastly different outcomes and
access.209 Indigent individuals in states with few IVF clinics may
find themselves unable to undertake desired procedures, because
they cannot access clinics with policies that permit the creation of
savior children.210 This creates harm if those individuals have
children suffering rare genetic diseases, where a savior sibling may
be the only viable option.211 Conversely, rich individuals are able
to “shop around” skirting any local clinic policy by traveling to
whichever clinic is willing to perform the desired procedure.212
This is not to say that there will not be challenges. The lack of
direct governmental involvement in healthcare, and IVF, will
make it difficult for the government to begin the arduous task of
carving out a regulatory space. The question of whether any
potential regulation should be left to individual States will be a
difficult one and is beyond the scope of this Article. Additionally, it
will be difficult to truly ascertain parental motive in many
instances of assisted reproduction, as parents could easily obscure
the true motive behind seeking IVF and PGD, to skirt any formal
regulation regarding savior children.
Current lack of consensus on the controversial issues related
to birth and pediatric donation significantly complicates any
national push on this issue.213 Given the general political gridlock
and the specific divisiveness of issues associated with
reproduction, it is difficult to imagine politicians working together
to put forth a truly bi-partisan regulatory scheme. As the UK has
209. See Alexandra Sifferlin, Millions of Women Don’t Have Access to Fertility
Treatments in the U.S., TIME (Mar. 14, 2017), http://time.com/4701023/fertilitytreatments-ivf/ (explaining that forty percent of women in the United States do
not have access to certain fertility treatments) (on file with the Washington & Lee
Journal of Civil Rights & Social Justice).
210. See generally Smith, supra note 207.
211. See generally id.
212. See id. at 99 (“In the present study, higher income and college-educated
women were much more likely to choose more expensive treatment path-ways.”).
213. See generally Democrats, Republicans Offer Competing Birth Control
Bills, CBSNEWS (June 9, 2015), https://www.cbsnews.com/news/democrats-repub
licans-offer-competing-birth-control-bills/ (illustrating the current lack of
consensus between the two political parties regarding birth control) (on file with
the Washington & Lee Journal of Civil Rights & Social Justice).

SAVIOR SIBLINGS IN THE UNITED STATES

455

demonstrated, it is essential that any regulation reflect the input
of many diverse stakeholders (from doctors, to bioethicists, to
lawyers, to disability rights advocates, to clergy, to sociologists) to
ensure that the broad range of views on this issue are addressed
and respected.214 While no regulatory framework will please
everyone, this should not be the goal, especially for a novel
procedure where cultural and scientific attitudes are still evolving.
However, by consulting interdisciplinary stakeholders from a
variety of political and religious affiliations regulators can put
forth the best possible plan, for the unique situation in the U.S.
B. Research
Efforts to advance a discussion on savior siblings are
hampered by the lack of robust data on this issue. We do not know
what the true effects, if any, are of the decision to have a savior
sibling on the ill child, the savior sibling, or the family dynamic. To
properly consider this dilemma, researchers must focus on these
questions and begin to gather data regarding savior siblings.215
Such research must examine both longitudinal psychological and
physical effects so that we can get the full picture of what it is to
be a savior sibling. Researchers must develop a multi-factorial
approach to examining the status of savior siblings. This will
involve studying families prior to initiation of the process, so we
can better understand what factors into the decision to have a
savior sibling. Research should continue, not just throughout the
donation process, but also in a longitudinal manner to investigate
whether there are long-term complications or effects from being a
savior sibling. Data must be gathered, so the fears discussed above
can be confirmed, or disproved. Of course, ethical concerns arise
when gathering large sets of data, especially if the data reveals
potentially sensitive health information, or puts individuals at risk
for harm.216 However, I am confident that, with proper planning

214. Telephone Interviews, supra note 192.
215. Susan M. Wolf et al., Using Preimplantation Genetic Diagnosis to Create
a Stem Cell Donor: Issues, Guidelines & Limits, 31 J.L. MED. & ETHICS 327,
331–32 (2003).
216. See generally Ben Berkman et al., supra note 127.
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and consideration, research into savior siblings can be designed
and conducted in an ethical manor.
Because this is a rare situation and not many savior siblings
currently exist or are created annually, it will take a long time to
generate statistically valid results. Although the population size
places a burden on getting useful information, it is likely that the
demand for this procedure will only increase in coming years. As
demand grows, there will be increased attention paid to savior
siblings, which will allow more robust research. Since no one
institution is likely to have significant numbers of subjects,
cooperative inter-institutional (or NIH) databases will be
important for data collection. Such efforts will ultimately provide
insight into ethical qualms that are currently theoretical.
C. Cord Banking
Umbilical cord blood has a very high concentration of
hematopoietic stem cells, which, as discussed above, can be
extremely helpful in fighting a wide range of conditions.217 Most
savior siblings are initially conceived to provide the life-saving
cells that come from umbilical cord blood and tissue.218 If cord blood
were more readily available, it would not be as necessary for
parents to create a savior sibling. If an appropriate match is
available, using banked cord blood could be preferable to creating
savior siblings, given the difficulty, cost, and time requirements of
the procedure. Expanding the availability of cord blood could
create an option for families who can’t afford (financially,
emotionally or due to the urgency of their sick child’s condition) to
go through the savior sibling process. Thus, there are numerous
clear benefits to cord blood banking.
Cord blood banks function similarly to regular blood banks,
but they are specifically for umbilical cord blood.219 The blood is
217. Hematopoietic Stem Cells, NAT’L INSTITUTES HEALTH (June 17, 2001),
https://stemcells.nih.gov/info/2001report/ chapter5.htm (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
218. Renece Waller-Wise, Umbilical Cord Blood: Information for Childbirth
Educators, U.S. NAT’L LIB. MEDICINE (2011), https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC3209739/ (on file with the Washington & Lee Journal of Civil Rights
& Social Justice).
219. Id.
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collected by a doctor following certain protocols and is then sent to
a bank where it is typed, tested, and stored for future use.220 This
information is stored, so that those in need of stem cells can be
connected with HLA matched donors.221
There are currently two options for cord blood banking: public
or private.222 Public banks are free, regulated by the FDA, and the
blood is HLA typed upon arrival.223 This allows quick action
whenever there is a request, and allows the blood to be available
for anyone to access.224 Private cord blood banks in contrast, can
be quite expensive, as parents pay an initial fee and a yearly
charge for storage.225 This service means that the blood is only
available for the family who banked it. Any cord blood from a child
who is eventually diagnosed with a genetic disease, inborn error of
metabolism, or leukemia, will not be useful in treating that child,
because the necessary cells will have the same mutation.226
Both public and private banking come with the benefit of
enabling significant research, on the nature of umbilical cords, and
the hematopoietic stem cells they contain. In order for cord blood
220. See Cord Blood Banking for Potential Future Transplantation, 119
PEDIATRICS 166, 167 (Jan. 2007), http://pediatrics.aappublications.org/content
/pediatrics/119/1/165.full.pdf (explaining the procedure associated with cord blood
banking and collection) (on file with the Washington & Lee Journal of Civil Rights
& Social Justice).
221. Id.
222. Comm. on Genetics and Comm. on Obstetric Practice, Committee
Opinion No. 648: Umbilical Cord Blood Banking, AM. C. OBSTETRICIANS &
GYNECOLOGISTS (Dec. 2015), https://www.acog.org/-/media/Committee-Opinions
/Committee-on-Genetics/co648.pdf?dmc=1&ts=20180130T1703512685 (on file
with the Washington & Lee Journal of Civil Rights & Social Justice).
223. See generally Merlin G. Butler & Jay E. Menitove, Umbilical Cord Blood
Banking: An Update, 28 J. ASSISTED REPROD. & GENETICS 669 (2011), https://link.
springer.com/article/10.1007/s 10815-011-9577-x (on file with the Washington &
Lee Journal of Civil Rights & Social Justice).
224. See Umbilical Cord Blood Banking, TEX. MED. ASS’N (Mar. 26, 2014),
https://www.texmed.org/Template.aspx?id=30321 (discussing advantages of
donating to a public cord blood bank) (on file with the Washington & Lee Journal
of Civil Rights & Social Justice).
225. See R. Morgan Griffin, Banking Your Baby’s Cord Blood: The Pros and
Cons, Costs, and Reasons Behind Saving your Newborn’s Umbilical Cord Blood,
WEBMD, http://www.webmd.com/ parenting/baby/features/banking-your-babyscord-blood (last visited on Apr. 17, 2018) (listing the three types of cord blood
banks and explaining that the private option is the most expensive) (on file with
the Washington &Lee Journal of Civil Rights & Social Justice).
226. Id.

458

24 WASH. & LEE J. CIVIL RTS. & SOC. JUST.419 (2018)

banking to offer a viable option as an approach to genetic diseases,
many people with diverse HLA types must donate. Given that this
current bounty is unrealized, it is understandable why twenty
states have passed laws that support a policy requiring physicians
to provide information to expecting parents regarding cord blood
options with different provisions.227
Increased cord banking can be accomplished while respecting
the rights and autonomy of the parents who decide to donate. One
step is requiring the primary physician of expectant parents to
discuss the available options for banking of cord blood before the
third trimester of pregnancy. Requiring the information be given
prior to the third trimester acts a precaution, while giving parents
time to consider the reasons why it makes sense to bank their cord
blood. It is important to give parents time to make an informed
decision regarding the practice before the birth of their child. If the
practice of banking cord blood becomes common, the availability of
cord blood for fighting future illnesses and research will greatly
increase and could reduce the need for savior siblings.
Cord blood banking is a particularly powerful tool, as
currently, most umbilical cords are simply discarded.228 This
means the medical community is throwing away a potentially
powerful tool in the battle against many rare diseases and
conditions. Furthermore, hematopoietic stem cells are free from
the contentious debate surrounding other forms of stem cells,
because they are harvested with no harm to any living person,
embryo, or fetus.
D. New Technological Advances
As medicine and medical technology advances, the hope is that
living donors will become less important. The best option for this
227. See US Regulations, PARENT’S GUIDE TO CORD BLOOD FOUND.,
https://parentsguidecord blood.org/en/regulations (last visited on Apr. 17, 2018)
(providing an overview of the states that have passed legislation encouraging
physicians to provide expecting parents information on the value and options
regarding cord blood, such as cord blood banking) (on file with the Washington &
Lee Journal of Civil Rights & Social Justice).
228. See Donating Umbilical Cord Blood to a Public Bank, supra note 97
(“After your baby is born, the umbilical cord and placenta are usually thrown
away.”).
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is through research leading to the discovery of more advanced
therapeutics. New treatments that target and treat the underlying
condition are always preferable to utilizing a living donor.
Other future directions are more fraught with potential
ethical and legal implications. Expanding our understanding and
utilization of stem cell therapies could be another way to cure
debilitating conditions, which presently require transplantation.229
Other potential future approaches include the development of
technologies like 3D Organ Printing,230 mechanical organs,231 or
the use of cross species transplantation.232 Potentially, advances in
human cloning could allow scientists to replicate unique biological
material, entirely without the need for any individual, other than
the sick person, to serve as a donor. Although these possibilities
raise significant ethical issues in their own right, they could make
the need for a savior sibling obsolete.
E. Final Thoughts
Few topics raise as many ethical concerns as does the debate
over the acceptability of savior siblings. Indeed, the issue of savior
229. Robert Sparrow & David Cram, Saviour Embryos? Preimplantation
Genetic Diagnosis as a Therapeutic Techonology, 20 REPROD. BIOMEDICINE ONLINE
667, 667–68 (2010), http://www.rbmojournal.com/ article/S1472-6483(09)002922/pdf (explaining that new advances in stem cell research have expanded to
embryotic stem cells) (on file with the Washington & Lee Journal of Civil Rights
& Social Justice); see generally Kazutoshi Takahashi et al., Induction of
Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors, 131
CELL 861–72 (2007), http://www.cell.com/cell/pdf/S0092-8674(07)01471-7.pdf
(discussing the potential uses of pluripotent stem cells) (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
230. Tim Lewis, Could 3D Printing Solve the Organ Transplant Shortage?,
GUARDIAN (July 30, 2017), https://www.theguardian.com/technology/2017/jul/30
/will-3d-printing-solve-the-organ-transplant-shortage
(on
file
with
the
Washington & Lee Journal of Civil Rights & Social Justice).
231. Matthew Shaer, Soon, Your Doctor Could Print a Human Organ on
Demand, SMITHSONIAN MAG. (May 2015), https://www.smithsonianmag.com/inno
vation/soon-doctor-print-human-organ-on-demand-180954951/ (on file with the
Washington & Lee Journal of Civil Rights & Social Justice).
232. See generally David K. C. Cooper, A Brief History of Cross-Species Organ
Transplantation, 25 BAYLOR U. MED. CTR. PROC. 49 (2012), https://www.ncbi
.nlm.nih.gov/pmc/articles/PMC3246856 /pdf/bumc0025-0049.pdf (explaining the
history of cross-species implantation) (on file with the Washington & Lee Journal
of Civil Rights & Social Justice).

460

24 WASH. & LEE J. CIVIL RTS. & SOC. JUST.419 (2018)

siblings seems to be an almost perfect storm, where values of
autonomy, consent, familial rights, and medical technology,
intersect in uncertain, and potentially problematic, ways.
It is important to remember that, in most cases, savior siblings
allow a sick child to extend their life, free from illness. This has
untold positive consequences, not just for the child, but for the
whole family unit. When considering the ethical conundrums, the
saving of a child’s life must be given weight in any ethical analysis.
Of course, we cannot turn a blind eye towards the potential for
abuse, or the ease with which this procedure could be misused, to
rapidly move in a direction that society is not comfortable with,
ethically or practically.
While the field has moved forward in the U.S. without any
guidance or regulation, the example of the UK shows that a
regulatory scheme is possible, and can succeed,233 even in a society
where the underlying issues are still contested. Such regulation
does not mean that progress will be halted, or that science and
autonomy will be irrevocably restricted. Rather, commonsense
regulation allows the genuine good to proceed, while protecting
children, and ensuring, to the greatest extent possible, that undue
harm is not occurring.
While the aim of this Article is not to develop specific
regulatory recommendations, a few elements stand out as
essential to any meaningful effort to allay concerns that the issue
of savior siblings will quickly devolve into unethical directions.
First, it makes fundamental sense to limit savior siblings’
donations to biological material short of organs. Indeed, the issues
of consent, harm, and autonomy, caution against allowing any
child to serve as an organ donor at a very young age, unless they
can persuasively demonstrate an understanding of the procedure.
Second, restricting savior child donation to immediate family
members can help address fears that families might make
improper decisions regarding who can be “saved” by a savior child.
Third, in order to ensure compliance, IVF clinics should report to
a monitoring body, with a special filing for families who want to
conceive, or are likely candidates to have, a savior child. This will
help ensure that uses can be documented, and that data can be
collected.
233.

Telephone Interviews, supra note 192.
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While these are preliminary suggestions, guidelines such as
these, if adopted, monitored, and enforced, can prevent the
situation from advancing in a more troubling direction.
Furthermore, regulatory efforts will begin to standardize care and
practice availability, so that different clinics do not offer wildly
different options to similarly situated individuals. Guidelines will
also allow uniform data to be gathered, permitting meaningful
assessment of savior siblings in the United States.
There is no question that savior siblings touch on a wide range
of difficult topics, from cultural and social attitudes about sickness,
birth, and family, to deeply held beliefs about medical technology,
the role of family, and tissue donation. Silence on the matter will
not lead to resolution. Efforts such as those discussed above, can
begin to change the situation of savior siblings in the United
States, so that the field can ethically proceed in a manner that
respects and protects savior siblings and their families.

